🔎 Trials Near Me

Domov › Rak prostate › Montana

Klinične študije za Rak prostate v Montana

17 študij za Rak prostate išče udeležence na lokacijah v Montana.

Mesta v Montana

Uradno besedilo študije (angleško)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Saint Vincent Frontier Cancer Center, Billings
  • in še 4
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • Benefis Sletten Cancer Institute, Great Falls
  • in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • in še 7
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Billings Clinic Cancer Center, Billings
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • in še 3
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06136650

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Billings Clinic Cancer Center, Billings
  • Benefis Sletten Cancer Institute, Great Falls
  • Hi-Line Sletten Cancer Center, Havre
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 10. sep. 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • Benefis Sletten Cancer Institute, Great Falls
  • in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 19. avg. 2026 · NCT04423211

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • in še 7
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 14. jul. 2026 · NCT06592924

Integrated Cancer Repository for Cancer Research

  • Bozeman Health Deaconess Hospital, Bozeman
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

  • Billings Clinic Cancer Center, Billings
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 14. apr. 2026 · NCT06235697

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

  • University of Montana, Missoula
Vključevanje udeležencevFaza 2
Starost 18–89 · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT07001241

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Deaconess Hospital, Bozeman
  • in še 4
Vključevanje udeležencevFaza 2
Starost 18 in več · Moški · Posodobljeno 29. jan. 2026 · NCT05806515

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • in še 4
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 22. jan. 2026 · NCT06470243

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Billings
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Billings Clinic Cancer Center, Billings
  • Bozeman Deaconess Hospital, Bozeman
  • Saint James Community Hospital and Cancer Treatment Center, Butte
  • in še 2
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 11. sep. 2025 · NCT03678025

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.